Susanna Passetti

Learn More
Over the last decade, a number of distinct mutations in the mtDNA (mitochondrial DNA) have been found to be associated with both syndromic and non-syndromic forms of hearing impairment. Their real incidence as a cause of deafness is poorly understood and generally underestimated. Among the known mtDNA mutations, the A1555G mutation in the 12S gene has been(More)
The preservation of residual hearing is becoming a high priority in cochlear implant surgery. It allows better speech understanding and ensures long-lasting and stable performance; it also allows the possibility, in selected cases, of combining electro-acoustic stimulation in the same ear. We present the results of a retrospective study of the conservation(More)
PURPOSE People who receive a unilateral cochlear implant find speech perception in acoustically complex situations very challenging, in part because they do not have access to binaural hearing. For cochlear implant patients with some residual hearing in the nonimplanted ear, bilateral auditory input can be obtained by the use of a cochlear implant and a(More)
Post-implantation facial nerve stimulation is one of the best known and most frequent complications of the cochlear implant procedure. Some conditions, such as otosclerosis and cochlear malformations, as well as high stimulation levels that may be necessary in patients with long auditory deprivation, expose patients to a higher risk of developing(More)
Mitochondrial diseases (MD) are a clinically heterogeneous group of disorders that arise as a result of dysfunction of the mitochondrial respiratory chain. Sensorineural hearing loss (SNHL) is often associated to mitochondrial dysfunctions both in syndromic, nonsyndromic forms. SNHL has been described in association to different mitochondrial multisystemic(More)
CONCLUSION Our results attest that the Otologics MET Carina(™) is a viable treatment for moderate to severe sensorineural hearing loss (SNHL) and for cases of mixed hearing loss, and that in selected cases it could represent an alternative to conventional hearing aids. OBJECTIVES To describe our experience with the fully implantable Carina(™) in eight(More)
  • 1